Dr. Reddy’s Laboratories Ltd ADR(RDY)는 NYSE에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $12.20 (+0.08%), 시가총액 $11.36B, PER (주가수익비율) 25.68, 52주 최저~최고 $12.46 ~ $16.17.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredien
Dr. Reddy’s Laboratories Ltd ADR의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
Dr. Reddy’s Laboratories Ltd ADR의 현재 주가는 $12.20 (+0.08%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
Dr. Reddy’s Laboratories Ltd ADR의 시가총액은 약 $11.36B입니다. PER은 25.68입니다.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global